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Review Article
Gestational diabetes mellitus — a forerunner of chronic
disorders in mother and child
Romaina Iqbal,1 Sobia Jawaid,2 Abdul Jabbar,3 Rahat Qureshi4

Department of Community Health Sciences,1,2 Department of Medicine,3 Department of Obstetric and Gynecology,4 The Aga Khan University, Karachi.

Abstract

Gestational Diabetes Mellitus (GDM) can have serious
immediate as well as long term consequences, both for the
mother as well as the off-spring. It seems that women of south
Asian origin are not only more likely to have GDM but also
suffer more from the adverse consequences of the disorder.
These consequences include the development of type 2 DM in
women with a history of GDM and a higher risk of obesity and
metabolic syndrome in the off-spring. Pakistani physicians
should consider GDM seriously because the WHO states that
rise in the prevalence of type 2 DM will mainly occur in
developing countries such as ours. Since GDM can lead to
development of type 2 DM, efforts should be made to prevent
type 2 DM through lifestyle modification strategies in this
high risk population. It is important that we develop some
clear cut guidelines for prevention and treatment of GDM.
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What is gestational diabetes mellitus?

The World Health Organization and the American
Diabetes Association define GDM (GDM) as "Any degree of
glucose intolerance with onset or first recognition during
pregnancy."1,2 The term GDM is not used for type1 or type 2
diabetes mellitus (DM) diagnosed before conception. In
addition, this term is not dependent on the use of insulin
during pregnancy or to the continuation of the diabetic state
after the pregnancy is over.3

Adverse consequences of GDM:

GDM can have deleterious consequences for the
mother as well as the off-spring. These consequences may be
observed at the time of delivery, which will be referred as
immediate consequences or they may appear later in life,
which will be referred to as long-term consequences. Both will
be reviewed.
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Immediate adverse consequences of GDM for
the mother:

Women with uncontrolled plasma glucose levels
during pregnancy have immediate adverse consequences, in
the form of obstetric complications, such as pre-eclampsia,
preterm deliveries, still births, caesarian sections and insulin
treatment.3,4 In Asian Indian women diagnosed with GDM up
to 8.2% preterm deliveries have been reported.5 Moreover, in
another Indian study one in six women who were diagnosed
as having GDM continued to have diabetes even after the
pregnancy was over.6 During pregnancy, such women develop
changes in their fasting lipid level, blood pressure, large and
small vessel function which causes hypertensive
complications such as pregnancy induced hypertension and
eclampsia.7 Metabolic syndrome is a condition which
involves central obesity, plus any two of the following factors,
raised triglyceride levels, reduced HDL cholesterol, raised
blood pressure and raised fasting plasma glucose. During
pregnancy there is development of insulin resistance causing a
transient increase in lipid levels, in short a metabolic
syndrome-like condition.7

Immediate adverse consequences of GDM for
the offspring:

At birth, offspring of women with GDM are at an
increased risk of developing congenital malformations,
macrosomia, respiratory distress and hyperbilirubinaemia.3
Several studies have shown the association of GDM with
congenital malformations such as cardiac defects, (especially
patent ductus arteriosus), hypospadias, polydactyl and central
nervous system defects.8 It has been reported that 20% -30%
of births in women with GDM are complicated with
macrosomia due to high values of amino-acids, glucose and
lipid levels in the blood. Also increased insulin secretion in the
pancreas of the foetus causes macrosomia.9 In a South Indian
study, neonates of women with GDM were heavier with
greater than average head, chest and abdominal measurements
compared to neonates of women without GDM.10 This shows
that the hyperglycemic state of the mother has an effect on the
growth of the foetus since insulin release in the mother has
growth hormone - like effect on the foetus inutero.

Long Term Consequences of GDM:

Long term consequences for the mother:

Women with a history of GDM are at a greater risk of
developing various chronic diseases later in life such as
Diabetes Mellitus (DM), metabolic syndrome and
cardiovascular disease compared to women who did not
develop GDM in a pregnancy. In a follow-up study in a
Danish population, 39.9% women with a mild form of GDM
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(treated by diet alone) had developed type 2 DM in 9.8 years
after the index pregnancy.11,12 In another review, 2.6-70%
women with GDM progressed to type 2 DM, when women
were followed up from 6 weeks post partum to 28 years postpartum. The authors found that the lowest rates were from
studies that had the shortest follow-up period.13 Further more
it was observed that the highest increase in the development of
type 2 DM took place in the first five years after the index
pregnancy and then increased slowly.13 However there was no
comparison group in the above cited studies (women without
GDM) which makes it difficult to ascertain whether the
increase in DM incidence was due to having GDM in the past
or related to a secular effect. In a better designed study which
had a control group as well, subjects were followed for a
period of 11 years, the cumulative incidence for type 2 DM
and abnormal glucose tolerance was 13.8% and 42.2%
respectively in women who had GDM and 0 and 2.8%
respectively in women without GDM (P<0.05).14 In an Indian
retrospective study conducted 4.5±2 years after the index
pregnancy, crude prevalence of type 2 DM was 52% in
women with GDM as compared to the 4% observed in women
without GDM.6 These studies indicate that the risk of
developing type 2 DM is considerably higher in women
diagnosed with GDM than in women who did not have GDM.
Estimates of population attributable risk (PAR) for developing
type 2 DM after GDM suggest that between 10-30% (PAR
0.10-0.30, CI 0.06-0.41) of the women who develop type 2
DM would have experienced GDM.15
Reported progression rate for type 2 DM in women
with GDM indicate wide variation and inconsistencies. There
is controversy about the role of ethnicity in the development
of type 2 DM in women with GDM. In a recent study in the
UK 35% of the Indo-Asians had persistent glucose tolerance 3
months post partum compared with 7% of Caucasians and 5%
of the Afro-Caribbean subjects.16 Whereas in a systematic
review of several studies the effect of ethnicity became
insignificant when the analyses were adjusted for duration of
post-partum follow-up indicating that the data is not consistent
on the role of ethnicity in development of type 2 DM in
women with GDM.13 Women with GDM are also at a greater
risk of developing metabolic syndrome and coronary vascular
disease later in life. A cross sectional analysis of data collected
on parous women who had participated in the GENNID
(genetics of non-insulin dependent diabetes) study showed
that women with prior GDM were more likely to have the
metabolic syndrome compared to women who did not have
GDM (86.6% vs. 73.5%; p=0.001). They also had a higher
prevalence of CVD (15.5 vs. 12.4%, OR 1.85, 95% CI, 1.212.82) that occurred at a younger age and was independent of
metabolic syndrome and type 2 DM.17 Furthermore, the
vascular changes which develop during GDM lead to vascular
diseases in women during later years of life.3
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Long term consequences in the offspring:

Most studies done on off spring of GDM mothers have
assessed the association of birth weight and inutero exposure
to a diabetic environment with obesity and metabolic
syndrome in childhood. In an investigation of the effects of
intrauterine exposure on adiposity and blood pressure at three
years of age (n=1238) adiposity assessed by skin fold
measures was found to be higher in offspring of women with
GDM compared to offspring of women without GDM.18 In a
comparison of off-spring (average age 5.0 years) of mothers
with GDM, with those of diabetic fathers (ODF) and offspring of parents who did not have diabetes (controls) in India,
the BMI of offspring of mothers with GDM was significantly
higher than that of the other two groups.19 In another
investigation a positive dose response relationship was
observed between degrees of maternal hyperglycemia during
pregnancy adjusted for birth weight, maternal weight gain,
age, parity, ethnicity and obesity in children (n=9349) at 5-7
years of age.20
A longitudinal cohort study, compared the
development of metabolic syndrome in four groups of
children 6-11 years old, these were large for gestational age
offspring and appropriate for gestational age offspring of
mothers with GDM, with similar off springs of control
mothers. It was observed that large for gestational age
offspring of GDM mothers showed a higher prevalence of
developing the metabolic syndrome (50%), compared to off
spring of the other 3 groups.21 Likewise, observations in a
small cohort of children (average age 9 years), of a low risk
Caucasian population (n=89), showed that off spring of
mothers with GDM were at an increased risk of developing
glucose intolerance 22. Similar observations were made in
another study in which large for gestational age offspring of
women with GDM were at an increased risk of developing
insulin resistance at 6-11 years of age. Furthermore, the odds
ratio of developing diabetes in children of mothers with
Gestational diabetes compared with development of diabetes
in children of mothers without Gestational diabetes was 7.46
(CI 4.85 -11.50).21 Similarly, in a multi-ethnic population, the
odds of having type 2 DM after exposure to maternal GDM
inutero was 5.7 (CI 2.4-13.4).23
There are several plausible biological mechanisms
through which GDM increases the risk of an offspring to have
obesity or DM. In the early phase of intrauterine development
of the foetus in women with GDM, there is increased
vulnerability of having a defect in organogenesis and
physiologic function development when exposed to increased
levels of metabolic substrates, such as amino acids, glucose
and fatty acids.24,25 It has been estimated that 5-7 year old
children of mothers with GDM have increased prevalence of
obesity and metabolic syndrome, especially when they are
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heavier at birth.21 Moreover IUGR in a female fetus can also
result in women having GDM as adults.24

Why is it an important health problem for
Pakistan?

The World Health Organization estimates that the
number of people with diabetes mellitus (DM) will increase
from 150 million to 333 million by the year 2025.
Furthermore, this increase in the prevalence of DM will
mainly occur in the 45 -64 years age population, belonging to
the developing regions of the world.26

The prevalence of type 2 DM in Pakistan has been
estimated to be 10% -14% in various regions of the
country.27,28 Moreover even the younger population (18 years
age) is getting afflicted with type 2 DM.29 With increasing
prevalence of obesity in children and adolescents of the
country, there is an increased risk of rise in the prevalence of
type 2 DM.30
GDM is a common condition affecting 0.6%-15% of
all pregnancies each year, Globally.31 In Pakistan, a study
conducted in Karachi observed 8% prevalence of GDM.32
GDM has serious adverse immediate consequences for
the mother as well as the off-spring with major financial
implications. Furthermore since GDM clearly leads to the
development of type 2 DM in women later in life, it is
important that GDM be considered as an early warning sign of
type 2 DM occurrence. In the offspring this condition is
associated with development of obesity and metabolic
syndrome in childhood.

Solution:

There is a need to work at two levels in this high risk
population. One is to prevent the development of GDM per se
and the other is to organize programmes for reducing the
incidence of type 2 DM in this high risk group. In our
prospective cohort work (n=612) conducted in Karachi,
increased BMI (OR 1.09 (1.01-1.17)/increased body fat
percentage (OR 1.07(1.03-1.13), decreased physical activity
levels (OR 0.89 (0.79-0.99) and diet (OR 0.75 (0.60-0.95)
were independent modifiable predictors of GDM.32 Therefore
it is suggested that prevention programmess should target
improving physical activity levels, reducing weight and
improving diet of Pakistani women of reproductive age.

High BMI values and post partum impaired glucose
tolerance of women are strong clinical indicators for type 2
DM in women with GDM. Postpartum screening of women
with GDM should assess cholesterol and lipoprotein levels,
plasma glucose and BMI measurements in women to establish
a rigorous lifestyle plan, which includes diet and physical
activity to prevent development of GDM in subsequent
pregnancies, as well as type 2 DM and metabolic syndrome
J Pak Med Assoc

later in life. Awareness of the women with regard to the threat
of type 2 DM after GDM should be increased. It has been
suggested in several studies that better maternal education of
women with a history of GDM should be introduced. The best
time for motivating and educating women is during pregnancy
so that they carry it further during the postpartum period.33

For implementing these solutions the role of health
professionals cannot be ignored. They have a responsibility
towards the society to ensure better health. At present, there
are no standard guidelines for prevention and treatment of
GDM in Pakistan. There is a dire need for developing them to
address this important health area.
In summary, GDM can have serious immediate as well
as long term implications for the health of the mother as well
as the off-spring. In Pakistan the prevalence rate of type 2 DM
has been projected to rise in the future. Preventive strategies as
life style modifications including a healthy diet and physical
activity, will reduce the rate of obesity which in turn will go a
long way in curbing the rising incidence of Type 2 Diabetes
Mellitus.
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